FloridaMarijuana.net

AUGUST 16, 2018

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. They estimate that the number of people aged 65 years and older is expected to increase from 35 million in 2000 to 71 million in 2030. million in 2030. million in 2000 to 19.5

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

AUGUST 10, 2021

The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7 billion in 2030. It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. 2 Pain 1994 Apr;57(1):5-15.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

DECEMBER 17, 2021

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

Cannabis Law Report

FEBRUARY 3, 2022

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. Several CBD oils are available, including full-spectrum CBD oil, broad-spectrum CBD oil, and isolate oil.

Indica 40

Indica Oil Legalization Clinical Trials 40

The Cannigma

OCTOBER 20, 2021

In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. Is CBD legal in Switzerland?

Legalization 52

Legalization Decriminalization Patients Medicine 52

Cannabis Law Report

JUNE 24, 2021

Messages must be fact-based and a clear distinction must be made among the effective medical uses of cannabis products for some ailments, the use of cannabis products such as CBD in the so-called wellness industry and the consequences of the non-medical use of cannabis. Drug Use Rising, but Science-Based Treatment More Available.

Research and Development 99

Research and Development Supply Chain Pharmaceutical Treatment 99